BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15133821)

  • 1. Grip force abnormalities in de novo Parkinson's disease.
    Fellows SJ; Noth J
    Mov Disord; 2004 May; 19(5):560-5. PubMed ID: 15133821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Force overflow and levodopa-induced dyskinesias in Parkinson's disease.
    Wenzelburger R; Zhang BR; Pohle S; Klebe S; Lorenz D; Herzog J; Wilms H; Deuschl G; Krack P
    Brain; 2002 Apr; 125(Pt 4):871-9. PubMed ID: 11912119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Social and economic cost of L-Dopa-induced dyskinesias in patients with Parkinson's disease].
    Maurel F; Lilliu H; Le Pen C
    Rev Neurol (Paris); 2001 May; 157(5):507-14. PubMed ID: 11438770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of pallidotomy versus medical therapy for Parkinson's disease.
    Vitek JL; Bakay RA; Freeman A; Evatt M; Green J; McDonald W; Haber M; Barnhart H; Wahlay N; Triche S; Mewes K; Chockkan V; Zhang JY; DeLong MR
    Ann Neurol; 2003 May; 53(5):558-69. PubMed ID: 12730989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The beneficial effects of subthalamic nucleus stimulation on manipulative finger force control in Parkinson's disease.
    Nowak DA; Topka H; Tisch S; Hariz M; Limousin P; Rothwell JC
    Exp Neurol; 2005 Jun; 193(2):427-36. PubMed ID: 15869945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rating scales for dyskinesias in Parkinson's disease.
    Goetz CG
    Mov Disord; 1999; 14 Suppl 1():48-53. PubMed ID: 10493403
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease.
    Kum WF; Gao J; Durairajan SS; Man SC; Xie LX; Lu JH; Fong WL; Li M
    J Clin Neurosci; 2009 Aug; 16(8):1034-7. PubMed ID: 19428256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of subthalamic nucleus deep brain stimulation on precision grip abnormalities in Parkinson's disease.
    Fellows SJ; Kronenbürger M; Allert N; Coenen VA; Fromm C; Noth J; Weiss PH
    Parkinsonism Relat Disord; 2006 Apr; 12(3):149-54. PubMed ID: 16549385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease.
    Vidailhet M; Bonnet AM; Marconi R; Durif F; Agid Y
    Mov Disord; 1999; 14 Suppl 1():13-8. PubMed ID: 10493399
    [No Abstract]   [Full Text] [Related]  

  • 10. Hand coordination as a quantitative measure of motor abnormality and therapeutic response in Parkinson's disease.
    Benice TS; Lou JS; Eaton R; Nutt J
    Clin Neurophysiol; 2007 Aug; 118(8):1776-84. PubMed ID: 17576094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
    Morgante F; Espay AJ; Gunraj C; Lang AE; Chen R
    Brain; 2006 Apr; 129(Pt 4):1059-69. PubMed ID: 16476674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976-1990.
    Van Gerpen JA; Kumar N; Bower JH; Weigand S; Ahlskog JE
    Arch Neurol; 2006 Feb; 63(2):205-9. PubMed ID: 16476808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manual transport in Parkinson's disease.
    Hejduková B; Hosseini N; Johnels B; Ingvarsson PE; Steg G; Olsson T
    Mov Disord; 2003 May; 18(5):565-72. PubMed ID: 12722171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levodopa in the early treatment of Parkinson's disease.
    Murata M
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S17-20. PubMed ID: 19131036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype and smoking history affect risk of levodopa-induced dyskinesias in Parkinson's disease.
    Strong JA; Dalvi A; Revilla FJ; Sahay A; Samaha FJ; Welge JA; Gong J; Gartner M; Yue X; Yu L
    Mov Disord; 2006 May; 21(5):654-9. PubMed ID: 16435402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordination of grip and load forces during vertical point-to-point movements with a grasped object in Parkinson's disease.
    Nowak DA; Hermsdörfer J
    Behav Neurosci; 2002 Oct; 116(5):837-50. PubMed ID: 12369804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bradykinesia in patients with Parkinson's disease having levodopa-induced dyskinesias.
    Ghassemi M; Lemieux S; Jog M; Edwards R; Duval C
    Brain Res Bull; 2006 May; 69(5):512-8. PubMed ID: 16647580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Movement patterns of peak-dose levodopa-induced dyskinesias in patients with Parkinson's disease.
    Gour J; Edwards R; Lemieux S; Ghassemi M; Jog M; Duval C
    Brain Res Bull; 2007 Sep; 74(1-3):66-74. PubMed ID: 17683791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease.
    Alonso-Frech F; Zamarbide I; Alegre M; Rodríguez-Oroz MC; Guridi J; Manrique M; Valencia M; Artieda J; Obeso JA
    Brain; 2006 Jul; 129(Pt 7):1748-57. PubMed ID: 16684788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levodopa-dyskinesia incidence by age of Parkinson's disease onset.
    Kumar N; Van Gerpen JA; Bower JH; Ahlskog JE
    Mov Disord; 2005 Mar; 20(3):342-4. PubMed ID: 15580606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.